Occupational Therapists in Sunnyvale, CA Accepting Medicare

46 Occupational Therapists found. Showing 41 - 46

Ms. Neelambari Paradkar, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 898 Firethorn Ter, Sunnyvale, CA 94086 Phone: 408-462-9649

Karyna Melissa Brandariz, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1290 Lawrence Station Rd, Sunnyvale, CA 94089 Phone: 408-743-5332

Maiko Ibay, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1085 W El Camino Real, Sunnyvale, CA 94087 Phone: 408-523-3060

Dr. Diane Tom, OTD, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 243 Twinlake Dr, Sunnyvale, CA 94089 Phone: 650-336-4694

Zahava Zuniga Occupational Therapist - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 970 W El Camino Real Ste 7, Sunnyvale, CA 94087 Phone: 650-938-2235

Ms. Shigrid Rose Marie Mantalaba Estrada Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 W California Ave, Apartment 804, Sunnyvale, CA 94086 Phone: 408-824-8036

News Archive

First steps taken to treat human hereditary blindness

A team led by Krzysztof Palczewski, Ph.D., chair of pharmacology at the Case Western Reserve University School of Medicine, has taken the first steps in treating an eye disease causing irreversible congenital blindness in millions of people worldwide by successfully testing two new treatments in mice.

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Researchers first gave the drug, mannitol, to provide temporary passage through the blood-brain barrier then transfused human umbilical cord blood cells into a stroke animal model. When used in the first hours and days following a stroke, stroke size decreased by 40 percent and resulting disability was significantly reduced.

Sanofi-aventis and Harvard University enter research collaboration

Sanofi-aventis announced today a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between Harvard University and sanofi-aventis. The focus of this collaboration is translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation.

Repeated exposure to low level blasts causes harmful effects in brain

Repeated exposure to low level blasts (LLB) can cause symptoms similar to sports concussion. Soldiers or law enforcement officers called "breachers" receive training in using low level blasts for forced entry.

Autoimmune response mediated by T lymphocytes may play vital role in pathogenesis of biliary atresia

Biliary atresia (BA) is an inflammatory obliterative cholangiopathy with unknown etiology, leading to progressive fibrosis and cirrhosis. Microarray technology, emerged as an indispensable research tool for gene expression profiling, has been used to study the mechanism underlying BA, and allows the simultaneous analysis of thousands of transcripts within a single experiment.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3(current)